GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Cyclically Adjusted Revenue per Share

Henan Lingrui Pharmaceutical Co (SHSE:600285) Cyclically Adjusted Revenue per Share : ¥3.97 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Henan Lingrui Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥1.604. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.97 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Henan Lingrui Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 12.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Henan Lingrui Pharmaceutical Co was 15.60% per year. The lowest was 3.10% per year. And the median was 11.80% per year.

As of today (2024-06-09), Henan Lingrui Pharmaceutical Co's current stock price is ¥24.85. Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥3.97. Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 6.26.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Henan Lingrui Pharmaceutical Co was 12.94. The lowest was 3.02. And the median was 4.72.


Henan Lingrui Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.27 2.58 2.97 3.42 3.84

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.52 3.62 3.75 3.84 3.97

Competitive Comparison of Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Henan Lingrui Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Henan Lingrui Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.604/115.2271*115.2271
=1.604

Current CPI (Mar. 2024) = 115.2271.

Henan Lingrui Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.392 98.200 0.460
201409 0.412 98.900 0.480
201412 0.334 99.000 0.389
201503 0.521 99.900 0.601
201506 0.458 99.500 0.530
201509 0.547 100.500 0.627
201512 0.531 100.600 0.608
201603 0.633 102.200 0.714
201606 0.569 101.400 0.647
201609 0.647 102.400 0.728
201612 0.692 102.600 0.777
201703 0.700 103.200 0.782
201706 0.705 103.100 0.788
201709 0.795 104.100 0.880
201712 0.958 104.500 1.056
201803 0.935 105.300 1.023
201806 0.931 104.900 1.023
201809 0.832 106.600 0.899
201812 0.785 106.500 0.849
201903 0.994 107.700 1.063
201906 1.005 107.700 1.075
201909 0.901 109.800 0.946
201912 0.846 111.200 0.877
202003 0.866 112.300 0.889
202006 1.199 110.400 1.251
202009 1.010 111.700 1.042
202012 1.022 111.500 1.056
202103 1.037 112.662 1.061
202106 1.372 111.769 1.414
202109 1.231 112.215 1.264
202112 1.116 113.108 1.137
202203 1.194 114.335 1.203
202206 1.421 114.558 1.429
202209 1.373 115.339 1.372
202212 1.273 115.116 1.274
202303 1.389 115.116 1.390
202306 1.597 114.558 1.606
202309 1.437 115.339 1.436
202312 1.421 114.781 1.427
202403 1.604 115.227 1.604

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Henan Lingrui Pharmaceutical Co  (SHSE:600285) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Henan Lingrui Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=24.85/3.97
=6.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Henan Lingrui Pharmaceutical Co was 12.94. The lowest was 3.02. And the median was 4.72.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Henan Lingrui Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Traded in Other Exchanges
N/A
Address
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
Executives
Wu Xi Zhen Director
Li Jin Supervisors
Ye Qiang senior management
Chen Yan Directors, senior managers
Wu Hui Bin senior management
Yu Peng Director
Zhao Zhi Jun Director
Li Lei senior management
Feng Guo Xin Directors, senior managers
Pan Zi Run Director
Xiong Wei Zheng Director
Tang Wei Supervisors
Cheng Jian Jun Director
Zhang Jun Bing Director
Xia Hui senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines